Citation: E. Allemann et al., DRUG-LOADED NANOPARTICLES - PREPARATION METHODS AND DRUG TARGETING ISSUES, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 173-191
Citation: H. Kublik et Bw. Muller, RHEOLOGICAL PROPERTIES OF POLYMER-SOLUTIONS AS CARRIERS FOR NASAL DRUG-DELIVERY SYSTEMS, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 192-196
Authors:
OJANTAKANEN S
HANNULA AM
MARVOLA M
KLINGE E
MAKIPAA M
Citation: S. Ojantakanen et al., BIOAVAILABILITY OF IBUPROFEN FROM HARD GELATIN CAPSULES CONTAINING SUCRALFATE OR SODIUM ALGINATE AS DILUENT, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 197-201
Citation: B. Provent et al., PARTICLE-SIZE AND THE CAKING TENDENCY OF A POWDER, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 202-207
Citation: K. Duckova et al., SILICONE-RUBBER - HYDROGEL COMPOSITES AS POLYMERIC BIOMATERIALS .5. TRANSDERMAL THERAPEUTIC SYSTEMS BASED ON HYDROGEL FILLED SILICONE-RUBBER, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 208-211
Authors:
RAHMAN AAA
SALEH SI
NAKAI Y
ABOUTALEB AE
AHMED MO
Citation: Aaa. Rahman et al., MOLECULAR BEHAVIOR AND DISSOLUTION CHARACTERISTICS OF FLUNITRAZEPAM IN-GROUND MIXTURES WITH CYCLODEXTRINS, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 212-215
Citation: Yp. Li et al., EFFECT OF A CONJUGATED BILE-SALT ON THE PULMONARY ABSORPTION OF INSULIN IN RATS, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 216-221
Citation: Jp. Skelly et Ma. Gonzalez, FDA UPDATE - DISSOLUTION TESTING - SIMPLE TOOL - IMPORTANT CONTRIBUTION, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 222-223
Citation: H. Blasius, REPORT ON THE OPERATION OF THE COMMITTEE-FOR-PROPRIETARY-MEDICINAL PRODUCTS (CPMP) DURING 1991 AND 1992, European journal of pharmaceutics and biopharmaceutics, 39(5), 1993, pp. 223-225
Citation: H. Vandoorne, INTERACTIONS BETWEEN CYCLODEXTRINS AND OPHTHALMIC DRUGS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 133-139
Authors:
CEFALI EA
BANFIELD CR
GONZALEZ MA
WAGNER JG
Citation: Ea. Cefali et al., IN-VIVO DETERMINATION OF ZERO-ORDER ABSORPTION FROM A TRANSDERMAL GLYCEROL TRINITRATE SYSTEM, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 140-143
Authors:
WILDING IR
DAVIS SS
SPARROW RA
SMITH KJ
SINCLAIR KA
SMITH AT
Citation: Ir. Wilding et al., THE EVALUATION OF AN ENTERIC-COATED NAPROXEN TABLET FORMULATION USINGGAMMA-SCINTIGRAPHY, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 144-147
Citation: Kh. Fromming et al., INCLUSION-COMPOUNDS OF CHOLESTEROL AND BETA-CYCLODEXTRIN, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 148-152
Citation: Jm. Newton et al., THE MECHANICAL-PROPERTIES OF AN HOMOLOGOUS SERIES OF BENZOIC-ACID ESTERS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 153-157
Citation: Pc. Lerk et H. Sucker, THE EFFECT OF SUCROSE LAURATE AND PROPYL 4-HYDROXYBENZOATE COMBINATIONS ON MICROBIAL-GROWTH .2. EVALUATION OF GROWTH OF ESCHERICHIA-COLI AND STAPHYLOCOCCUS-AUREUS IN 2 LIQUID ORAL PHARMACEUTICAL FORMULATIONS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 158-161
Authors:
SKELLY JP
VANBUSKIRK GA
ARBIT HM
AMIDON GL
AUGSBURGER L
BARR WH
BERGE S
CLEVENGER J
DIGHE S
FOX D
GONZALEZ MA
GRAY VA
HOIBERG C
JERUSSI R
LEESON LJ
LESKO L
MALINOWSKI H
NIXON PR
PEARCE DM
PECK G
PORTER S
ROBINSON J
SAVELLO DR
SCHWARTZ P
SCHWARTZ JB
SHAH VP
THEEUWES F
WHEATLEY T
Citation: Jp. Skelly et al., WORKSHOP-II REPORT - SCALE-UP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 162-167
Citation: H. Blasius, HARMONIZING OF INSPECTIONS WITHIN THE EC-MEMBER STATES, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 168-169
Citation: Ay. Ozer et al., TEMPERATURE-SENSITIVE AND PH-SENSITIVE LIPOSOMES, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 97-101
Citation: R. Groning et S. Weyel, ELECTRONICALLY CONTROLLED-RELEASE OF DRUGS FROM CAPSULES, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 102-104
Citation: O. Reer et Bw. Muller, INVESTIGATION OF THE INFLUENCE OF COSOLVENTS AND SURFACTANTS ON THE COMPLEXATION OF DEXAMETHASONE WITH HYDROXYPROPYL-BETA-CYCLODEXTRIN BY USE OF A SIMPLEX LATTICE DESIGN, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 105-111
Citation: P. Merkku et al., USE OF 3(3) FACTORIAL DESIGN AND MULTILINEAR STEPWISE REGRESSION-ANALYSIS IN STUDYING THE FLUIDIZED-BED GRANULATION PROCESS .2., European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 112-116
Citation: J. Rak et al., POLYACRYLATE TERPOLYMER FOR PROLONGED DRUG-RELEASE TYPE FORMULATIONS, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 117-119
Citation: Pc. Lerk et H. Sucker, THE EFFECT OF SUCROSE LAURATE AND PROPYL 4-HYDROXY-BENZOATE COMBINATIONS ON MICROBIAL-GROWTH .1. GROWTH OF ESCHERICHIA-COLI AND STAPHYLOCOCCUS-AUREUS IN TRYPTICASE SOYA BROTH (TSB) MEDIUM, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 120-127
Citation: Ma. Gonzalez, FDA UPDATE A NEW PRESIDENT AND THE PROMISE OF A NEW HEALTH-CARE SYSTEM, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 128-129
Citation: H. Blasius, NEW ANNEX TO THE EC-GMP-GUIDE - MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS, European journal of pharmaceutics and biopharmaceutics, 39(3), 1993, pp. 129-130